What's the drug?
Tirzepatide (Mounjaro) is Lilly's next generation therapy, targeting both GLP-1 and GIP
The US government stated $18000 per year was a fair price to pay.
There is no money in the cure. We sell you the disease, and charge you 5x for the treatment.
Fwiw I am obese.